Response Oncology - ROIX- Profile

Home » Directory » Health Care » Facilities & Health Systems » Ambulatory Care Centers » Response Oncology » Profile
Website: http://www.responseoncology.com

Phone: +1 901 761-7000
Address:
1805 Moriah Woods Blvd
Memphis, TENNESSEE 38117
Company Description
Response Oncology, Inc.. The Group's principal activity is to provide advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists. The Group conducts outcome research on behalf of pharmaceutical manufacturers. The Group presently operates 23 IMPACT Centers in 13 states, which provide high dose chemotherapy with stem cell support to cancer patients on an outpatient basis. The Group also provides pharmacy management services for certain medical oncology practices through its IMPACT Center pharmacies. Physician practice management accounted for 56% of 2001 revenues; Impact services, 43% and Cancer research services, 1%. Physician practice management accounted for 56% of 2001 revenues; Impact services, 43% and Cancer research services, 1%
Key People
Chairman, President & Chief Executive Charles E. Sweet
Executive Vice President & Chief Financial Officer Peter A. Stark

Related Business Topics
Breaking News
Reuters - November 23, 2009 5:16 AM
7:00am EST showComments allowSLCall replaceString(oldS, newS, fullS) return Share [] [] * Spectrum Completes Asia Partnerships For Apaziquone * Total Deal Value For South Korea Could Exceed $19 Million * Spectrum to Receive an Upfront Payment, ...
Reuters - November 23, 2009 5:07 AM
--First Evidence Of Bystander Effect On Visceral Metastases-- --Data Presented By Professor John F. Thompson, MD At 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers in Berlin-- KNOXVILLE, Tenn.--(Business Wire)-- Provectus ...
BBC - November 23, 2009 1:43 AM
The first sections of the Health and Social Services Department in Guernsey have moved into the new clinical block at the Princess Elizabeth Hospital. The department's Institute of Health and Social Care Studies has moved, but the whole building will not ...
Reuters - November 20, 2009 6:56 AM
Data Presented at International Melanoma Conference in Berlin Results Follow Decision by Company to Continue Phase 3 AGENDA Trial for Overall Survival BERKELEY HEIGHTS, N.J.--(Business Wire)-- Genta Incorporated (OTCBB: GETA.OB) announced preliminary ...
Forbes.com - November 20, 2009 5:40 AM
BusinessWire - --Results Follow Decision by Company to Continue Phase 3 AGENDA Trial for Overall Survival Genta Incorporated (OTCBB: GETA.OB) announced preliminary results that show a high objective response rate in a pilot study of patients with ...

More Response Oncology News

Cancer Treatment Centers
Talk with our oncology information specialists today about options.
CancerCenter.com
Medical Oncologist
Apply for Medical Oncologist Jobs in Your Area. Register Online Now.
AllHealthcareJobs.com
Oncology Care
Check Out Local.com To Find Oncology Care In Your Area!
Local.com
Overview  |  Profile  |  News  |  Quote & Financials